PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

March 8, 2021

Study Completion Date

July 8, 2021

Conditions

Osteoporotic Fractures

Interventions

DRUG

Teriparatide Prefilled Syringe

TPTD 20 mcg

DRUG

Placebo

Matching placebo as a prefilled syringe with all inactive ingredients

Trial Locations (1)

Hospital for Special Surgery, New York

All Listed Sponsors

collaborator

Weill Medical College of Cornell University

OTHER

lead

Hospital for Special Surgery, New York

OTHER

NCT02972424 - PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial | Biotech Hunter | Biotech Hunter